Clene Provides Update on ALS Clinical Development Meeting With FDA
Go back to Clene Provides Update on ALS Clinical Development Meeting With FDA| (NASDAQ: CLNN) | Delayed: 3.58 -0.07 (1.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.65 | 52 Week High | $ | |||
| Open | $3.72 | 52 Week Low | $ | |||
| Day High | $3.76 | P/E | N/A | |||
| Day Low | $3.52 | EPS | $ | |||
| Volume | 121,068 | |||||
